Prothrombin Complex Concentrate (PCC) - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Prothrombin Complex Concentrate (PCC) - Global Top Players Market Share and Ranking 2025

Prothrombin Complex Concentrate (PCC) - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-13
Report Id: 2765145
Industry: Pharma & Healthcare
Report Page: 111
Chart: 111

PDF Download

Publication Date: 2025-11-13
Report Id: 2765145
Industry: Pharma & Healthcare
Report Page: 111
Chart: 111

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Prothrombin Complex Concentrate (PCC) Definition
1.2 Global Prothrombin Complex Concentrate (PCC) Market Size and Forecast
1.2.1 By Consumption Value, Global Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
1.2.3 Global Prothrombin Complex Concentrate (PCC) Average Selling Price (ASP), 2020-2031
1.3 China Prothrombin Complex Concentrate (PCC) Market Size and Forecast
1.3.1 By Consumption Value, China Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
1.3.2 By Sales Quantity, China Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
1.3.3 China Prothrombin Complex Concentrate (PCC) Average Selling Price (ASP), 2020-2031
1.4 Share of China Prothrombin Complex Concentrate (PCC) Market with Respect to the Global Market
1.4.1 By Consumption Value, China Prothrombin Complex Concentrate (PCC) Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Prothrombin Complex Concentrate (PCC) Market Share in Global, 2020-2031
1.4.3 Prothrombin Complex Concentrate (PCC) Market Size: China VS Global, 2020-2031
1.5 Prothrombin Complex Concentrate (PCC) Market Dynamics
1.5.1 Prothrombin Complex Concentrate (PCC) Market Drivers
1.5.2 Prothrombin Complex Concentrate (PCC) Market Restraints
1.5.3 Prothrombin Complex Concentrate (PCC) Industry Trends
1.5.4 Prothrombin Complex Concentrate (PCC) Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Prothrombin Complex Concentrate (PCC), Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Prothrombin Complex Concentrate (PCC), Global Market Share by Company, 2020-2025
2.3 Prothrombin Complex Concentrate (PCC) Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Prothrombin Complex Concentrate (PCC) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Prothrombin Complex Concentrate (PCC) Concentration Ratio
2.6 Global Prothrombin Complex Concentrate (PCC) Mergers & Acquisitions, Expansion Plans
2.7 Global Prothrombin Complex Concentrate (PCC) Manufacturers Product Type
2.8 Head Office and Prothrombin Complex Concentrate (PCC) Production Site of Key Manufacturer
2.9 Prothrombin Complex Concentrate (PCC) Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Prothrombin Complex Concentrate (PCC), China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Prothrombin Complex Concentrate (PCC), China Market Share by Company, 2020-2025
3.3 China Prothrombin Complex Concentrate (PCC) Prothrombin Complex Concentrate (PCC) Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Prothrombin Complex Concentrate (PCC) Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Prothrombin Complex Concentrate (PCC) Capacity by Region
4.3 Global Prothrombin Complex Concentrate (PCC) Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Prothrombin Complex Concentrate (PCC) Production by Region, 2020-2031
4.5 Global Prothrombin Complex Concentrate (PCC) Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Prothrombin Complex Concentrate (PCC) Industry Chain
5.2 Prothrombin Complex Concentrate (PCC) Upstream Analysis
5.2.1 Prothrombin Complex Concentrate (PCC) Core Raw Materials
5.2.2 Main Manufacturers of Prothrombin Complex Concentrate (PCC) Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Prothrombin Complex Concentrate (PCC) Production Mode
5.6 Prothrombin Complex Concentrate (PCC) Procurement Model
5.7 Prothrombin Complex Concentrate (PCC) Industry Sales Model and Sales Channels
5.7.1 Prothrombin Complex Concentrate (PCC) Sales Model
5.7.2 Prothrombin Complex Concentrate (PCC) Typical Distributors

6 Sights by Type
6.1 Prothrombin Complex Concentrate (PCC) Classification by Type
6.1.1 100IU
6.1.2 200IU
6.1.3 300IU
6.1.4 400IU
6.1.5 1000IU
6.2 by Type, Global Prothrombin Complex Concentrate (PCC) Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Prothrombin Complex Concentrate (PCC) Consumption Value, 2020-2031
6.4 by Type, Global Prothrombin Complex Concentrate (PCC) Sales Quantity, 2020-2031
6.5 by Type, Global Prothrombin Complex Concentrate (PCC) Average Selling Price (ASP), 2020-2031

7 Sights by Usage Type
7.1 Prothrombin Complex Concentrate (PCC) Classification by Usage Type
7.1.1 Lyophilized Powder Form
7.1.2 Liquid Injection Form
7.2 by Usage Type, Global Prothrombin Complex Concentrate (PCC) Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Usage Type, Global Prothrombin Complex Concentrate (PCC) Consumption Value, 2020-2031
7.4 by Usage Type, Global Prothrombin Complex Concentrate (PCC) Sales Quantity, 2020-2031
7.5 by Usage Type, Global Prothrombin Complex Concentrate (PCC) Average Selling Price (ASP), 2020-2031

8 Sights by Manufacturing Process
8.1 Prothrombin Complex Concentrate (PCC) Classification by Manufacturing Process
8.1.1 Plasma-Derived
8.1.2 Recombinant Bioengineered
8.2 by Manufacturing Process, Global Prothrombin Complex Concentrate (PCC) Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Manufacturing Process, Global Prothrombin Complex Concentrate (PCC) Consumption Value, 2020-2031
8.4 by Manufacturing Process, Global Prothrombin Complex Concentrate (PCC) Sales Quantity, 2020-2031
8.5 by Manufacturing Process, Global Prothrombin Complex Concentrate (PCC) Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Prothrombin Complex Concentrate (PCC) Segment by Application
9.1.1 Hemophilia B
9.1.2 Acquired Coagulation Factor Deficiency
9.2 by Application, Global Prothrombin Complex Concentrate (PCC) Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Prothrombin Complex Concentrate (PCC) Consumption Value, 2020-2031
9.4 by Application, Global Prothrombin Complex Concentrate (PCC) Sales Quantity, 2020-2031
9.5 by Application, Global Prothrombin Complex Concentrate (PCC) Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Prothrombin Complex Concentrate (PCC) Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Prothrombin Complex Concentrate (PCC) Consumption Value, 2020-2031
10.3 By Region, Global Prothrombin Complex Concentrate (PCC) Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Prothrombin Complex Concentrate (PCC) Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Prothrombin Complex Concentrate (PCC) Market Size Market Share
10.5 Europe
10.5.1 Europe Prothrombin Complex Concentrate (PCC) Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Prothrombin Complex Concentrate (PCC) Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Prothrombin Complex Concentrate (PCC) Market Size Market Share
10.7 South America
10.7.1 South America Prothrombin Complex Concentrate (PCC) Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Prothrombin Complex Concentrate (PCC) Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Prothrombin Complex Concentrate (PCC) Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Prothrombin Complex Concentrate (PCC) Consumption Value, 2020-2031
11.3 By Country, Global Prothrombin Complex Concentrate (PCC) Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
11.4.2 by Type, United States Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
11.5.2 by Type, Europe Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
11.6.2 by Type, China Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
11.7.2 by Type, Japan Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
11.8.2 by Type, South Korea Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
11.10.2 by Type, India Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Prothrombin Complex Concentrate (PCC) Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 CSL Behring
12.1.1 CSL Behring Company Information, Head Office, Market Area, and Industry Position
12.1.2 CSL Behring Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 CSL Behring Company Profile and Main Business
12.1.5 CSL Behring Recent Developments
12.2 Grifols
12.2.1 Grifols Company Information, Head Office, Market Area, and Industry Position
12.2.2 Grifols Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.2.3 Grifols Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Grifols Company Profile and Main Business
12.2.5 Grifols Recent Developments
12.3 Octapharma
12.3.1 Octapharma Company Information, Head Office, Market Area, and Industry Position
12.3.2 Octapharma Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Octapharma Company Profile and Main Business
12.3.5 Octapharma Recent Developments
12.4 Prothya Biosolutions
12.4.1 Prothya Biosolutions Company Information, Head Office, Market Area, and Industry Position
12.4.2 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Prothya Biosolutions Company Profile and Main Business
12.4.5 Prothya Biosolutions Recent Developments
12.5 Takeda
12.5.1 Takeda Company Information, Head Office, Market Area, and Industry Position
12.5.2 Takeda Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.5.3 Takeda Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Takeda Company Profile and Main Business
12.5.5 Takeda Recent Developments
12.6 RAAS
12.6.1 RAAS Company Information, Head Office, Market Area, and Industry Position
12.6.2 RAAS Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.6.3 RAAS Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 RAAS Company Profile and Main Business
12.6.5 RAAS Recent Developments
12.7 Hualan Bio
12.7.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
12.7.2 Hualan Bio Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.7.3 Hualan Bio Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Hualan Bio Company Profile and Main Business
12.7.5 Hualan Bio Recent Developments
12.8 BOHUI
12.8.1 BOHUI Company Information, Head Office, Market Area, and Industry Position
12.8.2 BOHUI Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.8.3 BOHUI Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 BOHUI Company Profile and Main Business
12.8.5 BOHUI Recent Developments
12.9 NUOYI BIO
12.9.1 NUOYI BIO Company Information, Head Office, Market Area, and Industry Position
12.9.2 NUOYI BIO Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.9.3 NUOYI BIO Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 NUOYI BIO Company Profile and Main Business
12.9.5 NUOYI BIO Recent Developments
12.10 SINOPHARM
12.10.1 SINOPHARM Company Information, Head Office, Market Area, and Industry Position
12.10.2 SINOPHARM Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.10.3 SINOPHARM Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 SINOPHARM Company Profile and Main Business
12.10.5 SINOPHARM Recent Developments
12.11 Guangdong Weilun
12.11.1 Guangdong Weilun Company Information, Head Office, Market Area, and Industry Position
12.11.2 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.11.3 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Guangdong Weilun Company Profile and Main Business
12.11.5 Guangdong Weilun Recent Developments
12.12 Weiguang Bio
12.12.1 Weiguang Bio Company Information, Head Office, Market Area, and Industry Position
12.12.2 Weiguang Bio Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.12.3 Weiguang Bio Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.12.4 Weiguang Bio Company Profile and Main Business
12.12.5 Weiguang Bio Recent Developments
12.13 Kangbo Bio
12.13.1 Kangbo Bio Company Information, Head Office, Market Area, and Industry Position
12.13.2 Kangbo Bio Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.13.3 Kangbo Bio Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.13.4 Kangbo Bio Company Profile and Main Business
12.13.5 Kangbo Bio Recent Developments
12.14 Huarun Boya
12.14.1 Huarun Boya Company Information, Head Office, Market Area, and Industry Position
12.14.2 Huarun Boya Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.14.3 Huarun Boya Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.14.4 Huarun Boya Company Profile and Main Business
12.14.5 Huarun Boya Recent Developments
12.15 Taibang Biologic
12.15.1 Taibang Biologic Company Information, Head Office, Market Area, and Industry Position
12.15.2 Taibang Biologic Prothrombin Complex Concentrate (PCC) Models, Specifications, and Application
12.15.3 Taibang Biologic Prothrombin Complex Concentrate (PCC) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.15.4 Taibang Biologic Company Profile and Main Business
12.15.5 Taibang Biologic Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Prothrombin Complex Concentrate (PCC) should grow from US$ 1408 million in 2024 to US$ 2724 million by 2031, with a CAGR of 9.7% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Prothrombin Complex Concentrate (PCC)

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Mainly used to treat congenital and acquired coagulation factor II, VII, IX, and X deficiencies (alone or in combination) including: coagulation factor IX deficiency (hemophilia B), and coagulation factor II, VII, X deficiency overdose of anticoagulants, vitamin K deficiency; patients with hemorrhage caused by liver disease need to correct coagulation dysfunction; when disseminated intravascular coagulation (DIC) occurs, coagulation factors II, VII, IX, and X are consumed in large quantities, which can be used in heparin Application after chemotherapeutic; prothrombin time prolongation due to various reasons and intended for surgery, but may be ineffective for those with coagulation factor V deficiency; treatment of bleeding symptoms in patients with hemophilia A who have produced factor VIII preparations ; Reversal of coumarin anticoagulant-induced bleeding.In 2024, global Prothrombin Complex Concentrate (PCC) production reached approximately 4.73 m units, with an average global market price of around US$ 280 perunit.The average gross profit margin of this product is 80%.

The global PCC market is primarily driven by several key forces. The increasing use of anticoagulant drugs such as warfarin, rivaroxaban, and apixaban has led to a surge in demand for rapid anticoagulation reversal, particularly among the aging population suffering from atrial fibrillation and venous thromboembolism. In addition, the growing need for immediate hemostasis in trauma care and major surgeries has led hospitals to increase their PCC inventory and utilization. Compared with fresh frozen plasma (FFP), PCC offers lower infusion volumes, faster onset of action, and reduced risk of volume overload, making it widely preferred by clinicians. Furthermore, advancements in viral inactivation and plasma fractionation technologies have significantly improved product safety and purity, laying a solid technological foundation for market expansion.

Despite its promising outlook, the PCC market faces several challenges and risks. The limited and costly supply of human plasma, combined with stringent regulations on plasma collection and cross-border circulation, constrains production capacity. There are also concerns regarding thrombosis risks associated with repeated or high-dose use, leading to cautious adoption in clinical practice. In some regions, lower-cost alternatives such as FFP are still preferred, limiting PCC market penetration. Moreover, the emergence of recombinant hemostatic agents (e.g., recombinant Factor VIIa and four-factor recombinant PCC) may pose future competitive threats. Long regulatory approval timelines and strict safety monitoring requirements in the plasma products industry further restrain the sector’s development.

From a downstream perspective, PCC demand is expanding beyond traditional anticoagulant reversal into broader clinical applications. In Western markets, emergency departments and surgical units remain the primary end users, while in emerging economies, trauma centers and tertiary hospitals are becoming key growth drivers. PCC is increasingly used in managing coagulation disorders associated with liver disease, obstetric hemorrhage, and intraoperative bleeding in cardiac and neurosurgery. As clinical guidelines evolve and physician awareness improves, PCC adoption is becoming more standardized, solidifying its role in hospital inventories. Future product innovations focused on improved room-temperature stability and ready-to-use liquid formulations are expected to further accelerate market penetration.

The upstream supply chain of PCC production relies heavily on high-quality human plasma. Most plasma resources originate from well-established collection systems in North America and Europe, while Asia and Latin America are still expanding their capacities. Plasma collection volume, viral screening, cold-chain logistics, and fractionation technology directly determine the output and safety of PCC products. In recent years, major plasma product manufacturers have invested significantly in expanding their collection networks, promoting localization of the supply chain. Technological advancements in viral inactivation reagents, centrifugation systems, and purification resins have improved yield and reduced production risks. However, due to the highly regulated and ethically sensitive nature of plasma sourcing, the stability of upstream supply remains a critical constraint for the PCC industry.

This report studies and analyses global Prothrombin Complex Concentrate (PCC) status and future trends, helps the client to determine the Prothrombin Complex Concentrate (PCC) market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Prothrombin Complex Concentrate (PCC), and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Prothrombin Complex Concentrate (PCC) market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Prothrombin Complex Concentrate (PCC) sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Prothrombin Complex Concentrate (PCC) sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Prothrombin Complex Concentrate (PCC) key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Prothrombin Complex Concentrate (PCC) key producing regions, capacity, production, and year over year growth
(6) Prothrombin Complex Concentrate (PCC) industry chains, upstream, midstream and downstream
Market segment by players, this report covers
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
RAAS
Hualan Bio
BOHUI
NUOYI BIO
SINOPHARM
Guangdong Weilun
Weiguang Bio
Kangbo Bio
Huarun Boya
Taibang Biologic

Market segment by Type, covers
100IU
200IU
300IU
400IU
1000IU

Market segment by Usage Type, covers
Lyophilized Powder Form
Liquid Injection Form

Market segment by Manufacturing Process, covers
Plasma-Derived
Recombinant Bioengineered

Market segment by Application, can be divided into
Hemophilia B
Acquired Coagulation Factor Deficiency

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Prothrombin Complex Concentrate (PCC) product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Prothrombin Complex Concentrate (PCC) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Prothrombin Complex Concentrate (PCC) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Prothrombin Complex Concentrate (PCC), percent & CAGR, 2020-2031
Chapter 5: Prothrombin Complex Concentrate (PCC) industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.